Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71335-3179

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-3179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig (Atorvastatin Fig1)

A line chart showing cumulative incidence (%) over a period of 3.5 years comparing Atorvastatin and Placebo. The graph presents treatment effect with a hazard ratio (HR) of 0.64 and p-value of 0.0005, indicating lower cumulative incidence in the Atorvastatin group compared to Placebo.*

FDA Label Image

Fig (Atorvastatin Fig2)

A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups during up to 4 years of follow-up. The horizontal axis represents time in years to the first primary endpoint, and the vertical axis shows cumulative hazard as a percentage. The Atorvastatin group shows a consistently lower hazard compared to placebo.*

FDA Label Image

Fig (Atorvastatin Fig3)

A line graph depicting the percentage of subjects experiencing a major cardiovascular event over time in years for Atorvastatin 10 mg and Atorvastatin 80 mg dosages. The x-axis shows time to first major cardiovascular endpoint up to 5 years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with confidence interval 0.69-0.89 and p-value 0.0002 comparing the two dose groups.*

FDA Label Image

Str (Atorvastatin Str)

Chemical structure of Atorvastatin Calcium dihydrate, showing the molecular arrangement of atoms including aromatic rings, hydroxyl groups, and calcium ion complex.*

FDA Label Image

Label (Lbl713353179)

Atorvastatin Calcium Tablets USP, 80 mg film-coated oral tablets, packaged in a bottle of 30 tablets. The label includes the NDC 71335-3179-1, with storage instructions to keep at 20° to 25°C and dispensing in tight containers. Labeler is Bryant Ranch Prepack, and manufacturer is Aurobindo Pharma Limited. QR codes for dosage and package insert information are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.